NEOMYCIN AND POLYMYXIN B SULFATE
NEOMYCIN SULFATE; POLYMYXIN B SULFATE
Approval overview NEOMYCIN AND POLYMYXIN B SULFATE is listed in Drugs@FDA under application 065108 (ANDA).
Marketing status: Prescription Active ingredient NEOMYCIN SULFATE; POLYMYXIN B SULFATE Form and strength SOLUTION;IRRIGATION - EQ 40MG BASE/ML;200,000 UNITS/ML Sponsor XGEN PHARMS Submission history Latest submission status date: 2006-01-31 00:00:00.
Structured Monograph
Clinical summary
Approval overview NEOMYCIN AND POLYMYXIN B SULFATE is listed in Drugs@FDA under application 065108 (ANDA). Marketing status: Prescription Active ingredient NEOMYCIN SULFATE; POLYMYXIN B SULFATE Form and strength SOLUTION;IRRIGATION - EQ 40MG BASE/ML;200,000 UNITS/ML Sponsor XGEN PHARMS Submission history Latest submission status date: 2006-01-31 00:00:00. Submission type: ORIG.
Monitoring
- • Marketing status: Prescription
Interaction Notes
- No interaction notes stored yet.